Day 3 |
07.30-08.30 |
8.30-10.00 |
10.30-12.30 |
12.45-13.45 |
14.00-15.30 |
16.00-17.30 |
Hall 1 |
98- SS 12
Interpretative strategies for lung function tests |
104- Symposium 11
Science and research in European Union |
109- Symposium 15
Recent advances in the management of COPD |
119- MTP 8
Mycobacterial culture methods and recent developments |
129- Clinical Grand Round
Infections-Tbc |
134- MS 14
Respiratory Failure and Treatment |
Hall 2 |
99- SS 13
Prevalence of asthma and atopy: Reached a peak? |
105- Symposium 12
Venous tromboembolism |
110- Round Table 10
Chronic cough |
120- MTP 9
Prophylaxis of venous tromboembolism in medical patients |
130- Round Table 11
Multidrug resistant tuberculosis (MDR TB) |
135- Round Table 12
Clinical use of respiratory devices |
Hall 3 |
100- SS 14
New antibiotics: efficacy, safety |
106- Symposium 13
Childhood asthma |
111- Symposium 16
Non-small cell lung cancer: recent perspectives |
121- MTP 10
Diagnosis and treatment of mediastinal masses |
131- Symposium 18
Training for specialty in medicine: Recent advances |
136- Pro-Con Discussion
Do all obstructive sleep apnea patients have to be treated? |
Hall 4 |
101- SS 15
Bioaerosols and lung health |
107- MS 11
Respiratory Functional tests |
112- HT
- Cardiopulmonary effects of nanoparticles
- Lung transplantation
- The role of anti-inflammatory therapy in community acquired pneumonia
- Respiratory intensive care in neuromuscular disorders |
122- MTP 11
Toxic Pneumonitis |
132- MS 12
Cystic Fibrosis |
137- MS 15
Passive Smokers |
Hall 5 |
102- SS 16
Nuss operation |
108- Symposium 14
Noninvasive mechanical ventilation |
113- Symposium 17
Bronchiolitis in Adults |
123- MTP 12
Differential diagnosis in pediatric respiratory diseases |
133- MS 13
New Developments of OSAS |
138- MS 16
Community acquired pneumonia |
Hall 6 |
103- SS 17
New Legal Developments about Tobacco Control |
|
114- PDS16
Pediatric Chest Diseases and Sleep Disorders |
124- MTP 13
Cardiopulmonary exercise testing |
|
139- PDS21
Pediatric Chest Diseases |
Hall 7 |
|
|
115- PDS17
FEMTOS |
125- MTP 14
Determination of physical disability in respiratory diseases |
|
140- PDS22
Diagnosis Methods |
Hall 8 |
|
|
116- PDS18
Pulmonary Rehabilitation |
126- MTP 15
The strategies of tobacco industry in Turkiye |
|
141- PDS23
Lung and Pleural Malignancies |
Hall 9 |
|
|
117- PDS19
Experimental researches in Pulmonary Diseases |
127- MTP 16
Approach to the open lung biopsy pattern analysis of the pattern |
|
142- PDS24
Diagnosis and Treatment in Thoracic Surgery |
Hall 10 |
|
|
118- PDS20
Treatment Problems in Tuberculosis |
128- MTP 17
Organization and management of intensive care units |
|
143- PDS25
Thoracic Surgery: Diagnostic Procedures and Chest Wall Diseases |
Hall 11 |
|
|
|
|
|
|
Hall 12 |
|
|
|
|
|
|
Hall 13 |
|
|
|
|
|
|
Hall 14 |
|
|
|
|
|
|
Hall 15 |
|
|
|
|
|
|
Poster Hall |
|
|
|
|
|
144- Poster Presentation (P201-249)
145- Poster Presentation (P250-300)
|
